Implications of continued response after autologous stem cell transplantation for multiple myeloma

Patients undergoing autologous stem cell transplantation (ASCT) for multiple myeloma (MM) undergo disease assessment approximately 100 days later. Some patients continue to have a decline in their serum or urine monoclonal protein after day 100 in the absence of additional therapy. We evaluated 430...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Gonsalves, Wilson I., Gertz, Morie A., Dispenzieri, Angela, Lacy, Martha Q., Lin, Yi, Singh, Preet P., Gupta, Vinay, Hayman, Suzanne R., Buadi, Francis K., Dingli, David, Kapoor, Prashant, McCurdy, Arleigh R., Kumar, Shaji K.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2013
Teme:
Lymphoid Neoplasia
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3765057/
https://ncbi.nlm.nih.gov/pubmed/23863899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-03-492678
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items